Literature DB >> 20298200

Confirmed rare copy number variants implicate novel genes in schizophrenia.

Gloria W C Tam1, Louie N van de Lagemaat, Richard Redon, Karen E Strathdee, Mike D R Croning, Mary P Malloy, Walter J Muir, Ben S Pickard, Ian J Deary, Douglas H R Blackwood, Nigel P Carter, Seth G N Grant.   

Abstract

Understanding how cognitive processes including learning, memory, decision making and ideation are encoded by the genome is a key question in biology. Identification of sets of genes underlying human mental disorders is a path towards this objective. Schizophrenia is a common disease with cognitive symptoms, high heritability and complex genetics. We have identified genes involved with schizophrenia by measuring differences in DNA copy number across the entire genome in 91 schizophrenia cases and 92 controls in the Scottish population. Our data reproduce rare and common variants observed in public domain data from >3000 schizophrenia cases, confirming known disease loci as well as identifying novel loci. We found copy number variants in PDE10A (phosphodiesterase 10A), CYFIP1 [cytoplasmic FMR1 (Fragile X mental retardation 1)-interacting protein 1], K(+) channel genes KCNE1 and KCNE2, the Down's syndrome critical region 1 gene RCAN1 (regulator of calcineurin 1), cell-recognition protein CHL1 (cell adhesion molecule with homology with L1CAM), the transcription factor SP4 (specificity protein 4) and histone deacetylase HDAC9, among others (see http://www.genes2cognition.org/SCZ-CNV). Integrating the function of these many genes into a coherent model of schizophrenia and cognition is a major unanswered challenge.

Entities:  

Mesh:

Year:  2010        PMID: 20298200     DOI: 10.1042/BST0380445

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  61 in total

1.  Fragile X mental retardation protein levels are decreased in major psychiatric disorders.

Authors:  S Hossein Fatemi; Rachel E Kneeland; Stephanie B Liesch; Timothy D Folsom
Journal:  Schizophr Res       Date:  2010-08-19       Impact factor: 4.939

Review 2.  TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.

Authors:  Kazunori Suzuki; Haruhide Kimura
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

3.  GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.

Authors:  Jared W Young; Mary E Kamenski; Kerin K Higa; Gregory A Light; Mark A Geyer; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

Review 4.  The genetics of cognitive impairment in schizophrenia: a phenomic perspective.

Authors:  Robert M Bilder; Andrew Howe; Nic Novak; Fred W Sabb; D Stott Parker
Journal:  Trends Cogn Sci       Date:  2011-08-02       Impact factor: 20.229

5.  The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium.

Authors:  Raquel Pinacho; Nuria Villalmanzo; Jasmin Lalonde; Josep Maria Haro; J Javier Meana; Grace Gill; Belén Ramos
Journal:  Bipolar Disord       Date:  2011 Aug-Sep       Impact factor: 6.744

Review 6.  Mechanisms regulating dendritic arbor patterning.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Cell Mol Life Sci       Date:  2017-07-22       Impact factor: 9.261

7.  Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity.

Authors:  Ki-Jun Yoon; Ha Nam Nguyen; Gianluca Ursini; Fengyu Zhang; Nam-Shik Kim; Zhexing Wen; Georgia Makri; David Nauen; Joo Heon Shin; Youngbin Park; Raeeun Chung; Eva Pekle; Ce Zhang; Maxwell Towe; Syed Mohammed Qasim Hussaini; Yohan Lee; Dan Rujescu; David St Clair; Joel E Kleinman; Thomas M Hyde; Gregory Krauss; Kimberly M Christian; Judith L Rapoport; Daniel R Weinberger; Hongjun Song; Guo-Li Ming
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

Review 8.  Timing behavior in genetic murine models of neurological and psychiatric diseases.

Authors:  Ayşe Karson; Fuat Balcı
Journal:  Exp Brain Res       Date:  2021-01-06       Impact factor: 1.972

Review 9.  Histone acetylation: molecular mnemonics on the chromatin.

Authors:  Johannes Gräff; Li-Huei Tsai
Journal:  Nat Rev Neurosci       Date:  2013-01-17       Impact factor: 34.870

10.  HDAC9 is implicated in schizophrenia and expressed specifically in post-mitotic neurons but not in adult neural stem cells.

Authors:  Bing Lang; Tahani Mohammed A Alrahbeni; David St Clair; Douglas H Blackwood; Colin D McCaig; Sanbing Shen
Journal:  Am J Stem Cells       Date:  2011-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.